We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
126
ConocoPhillips
COP
$146B
$170M 0.16%
1,439,251
-152,031
-10% -$18.5M
DUK icon
127
Duke Energy
DUK
$95B
$170M 0.16%
1,646,284
+152,449
+10% +$14.6M
PNC icon
128
PNC Financial Services
PNC
$101B
$169M 0.16%
1,073,010
-2,731
-0.3% -$430K
UL icon
129
Unilever
UL
$135B
$168M 0.15%
2,957,508
-32,154
-1% -$1.72M
BBY icon
130
Best Buy
BBY
$17.3B
$166M 0.15%
2,074,368
-111,486
-5% -$8.21M
EL icon
131
Estee Lauder
EL
$31.5B
$165M 0.15%
665,806
+63,671
+11% +$14.2M
IWM icon
132
iShares Russell 2000 ETF
IWM
$81.6B
$163M 0.15%
937,199
+74,166
+9% +$13.2M
AZN icon
133
AstraZeneca
AZN
$252B
$163M 0.15%
1,200,199
-69,366
-5% -$8.7M
TT icon
134
Trane Technologies
TT
$106B
$161M 0.15%
955,612
-7,122
-0.7% -$1.18M
SO icon
135
Southern Company
SO
$105B
$160M 0.15%
2,237,113
+43,586
+2% +$2.91M
LOW icon
136
Lowe's Companies
LOW
$123B
$159M 0.15%
795,639
-58,876
-7% -$11.8M
SBUX icon
137
Starbucks
SBUX
$120B
$155M 0.14%
1,561,461
-206,822
-12% -$19.5M
WM icon
138
Waste Management
WM
$90.6B
$155M 0.14%
986,211
+7,096
+0.7% +$1.14M
SCHW
139
Charles Schwab
SCHW
$190B
$153M 0.14%
1,833,137
+140,504
+8% +$10.9M
USB icon
140
US Bancorp
USB
$100B
$151M 0.14%
3,460,722
-271,857
-7% -$11.6M
VEA icon
141
Vanguard FTSE Developed Markets ETF
VEA
$236B
$150M 0.14%
3,571,910
+576,211
+19% +$23.3M
IQV icon
142
IQVIA
IQV
$39.7B
$150M 0.14%
729,988
-17,397
-2% -$3.53M
DIVO icon
143
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.8B
$148M 0.14%
4,140,327
+915,927
+28% +$32.3M
VCIT icon
144
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
$147M 0.13%
1,892,802
-75,030
-4% -$5.77M
BA icon
145
Boeing
BA
$186B
$145M 0.13%
761,415
+13,722
+2% +$2.24M
ENB icon
146
Enbridge
ENB
$112B
$144M 0.13%
3,693,750
+162,290
+5% +$6.35M
CI icon
147
Cigna
CI
$74.1B
$144M 0.13%
434,691
+14,418
+3% +$4.56M
MRSH
148
Marsh
MRSH
$91.1B
$142M 0.13%
857,942
+130,036
+18% +$21.3M
IEI icon
149
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$141M 0.13%
1,230,061
+75,962
+7% +$8.71M
VGT icon
150
Vanguard Information Technology ETF
VGT
$148B
$141M 0.13%
3,528,768
+215,544
+7% +$8.79M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.